The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
Open accessAbstract
BACKGROUND: Fluoroquinolone-resistant Escherichia coli are increasingly prevalent. Their clonal origins--potentially critical for control efforts--remain undefined. METHODS: Antimicrobial resistance profiles and fine clonal structure were determined for 236 diverse-source historical (1967-2009) E. coli isolates representing sequence type ST131 and 853 recent (2010-2011) consecutive E. coli isolates from 5 clinical laboratories in Seattle, Washington, and Minneapolis, Minnesota. Clonal structure was resolved based on fimH sequence (fimbrial adhesin gene: H subclone assignments), multilocus sequence typing, gyrA and parC sequence (fluoroquinolone resistance-determining loci), and pulsed-field gel electrophoresis. RESULTS: Of the recent fluoroquinolone-resistant clinical isolates, 52% represented a single ST131 subclonal lineage, H30, which expanded abruptly after 2000. This subclone had a unique and conserved gyrA/parC allele combination, supporting its tight clonality. Unlike other ST131 subclones, H30 was significantly associated with fluoroquinolone resistance and was the most prevalent subclone among current E. coli clinical isolates, overall (10.4%) and within every resistance category (11%-52%). CONCLUSIONS: Most current fluoroquinolone-resistant E. coli clinical isolates, and the largest share of multidrug-resistant isolates, represent a highly clonal subgroup that likely originated from a single rapidly expanded and disseminated ST131 strain. Focused attention to this strain will be required to control the fluoroquinolone and multidrug-resistant E. coli epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PAUP^* : Phylogenetic Analysis Using Parsimony (and other methods) 4.0b8
Swofford, D. L. (2001) · Cited by 12,789
PAUP * [Phylogenetic Analysis Using Parsimony (and Other Methods)]
Cummings, M. P. (2004) · Dictionary of Bioinformatics and Computational Biology · doi:10.1002/0471650129.dob0522 · Cited by 5,215
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038 · cited 3×
“DOI: 10.1093/infdis/jis933 Dominant Multidrug-Resistant E. coli Strain • JID • 1 America guidelines recommended nitrofurantoin over FQs for empirical treatment of uncomplicated UTIs [5].”
InfluentialIntercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Self-citationRusso, T. A., & Johnson, J. R. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00049-2 · Cited by 801
Self-citationEscherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Emerging Mechanisms of Fluoroquinolone Resistance
Hooper, D. C. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010239 · Cited by 633
Self-citationJohnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Self-citationPeirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Self-citationAdaptation to the fitness costs of antibiotic resistance in Escherichia coli
Schrag, S. J., Perrot, V., & Levin, B. R. (1997) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1997.0178 · Cited by 396
M100-S11, Performance standards for antimicrobial susceptibility testing
(2001) · Clinical Microbiology Newsletter · doi:10.1016/s0196-4399(01)88009-0 · Cited by 274
Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Self-citationHigh-Resolution Two-Locus Clonal Typing of Extraintestinal Pathogenic Escherichia coli
Weissman, S. J., Johnson, J. R., Tchesnokova, V., Billig, M., Dykhuizen, D., Riddell, K., Rogers, P., Qin, X., Butler-Wu, S., Cookson, B. T., et al. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06663-11 · Cited by 172
Self-citationCagnacci, S., Gualco, L., Debbia, E., Schito, G. C., & Marchese, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Leflon‐Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M.-C., Duportail, F., Heym, B., Bingen, É., & Nicolas-Chanoine, M.-H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3736-3742.2004 · Cited by 149
Self-citationPlatell, J. L., Cobbold, R. N., Johnson, J. R., Heisig, A., Heisig, P., Clabots, C., Kuskowski, M. A., & Trott, D. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00306-11 · Cited by 116
Self-citationPlatell, J. L., Johnson, J. R., Cobbold, R. N., & Trott, D. J. (2011) · Veterinary Microbiology · doi:10.1016/j.vetmic.2011.05.007 · Cited by 111
Self-citationWeissman, S. J., Chattopadhyay, S., Aprikian, P., Obata‐Yasuoka, M., Yarova‐Yarovaya, Y., Stapleton, A. E., Ba‐Thein, W., Dykhuizen, D. E., Johnson, J. R., & Sokurenko, E. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04985.x · Cited by 104
Self-citationComparison ofEscherichia coliST131 Pulsotypes, by Epidemiologic Traits, 1967–2009
Johnson, J. R., Nicolas-Chanoine, M.-H., DebRoy, C., Castanheira, M., Robiscek, A., Hansen, G. T., Weissman, S. J., Urban, C. M., Platell, J. L., Trott, D. J., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1804.111627 · Cited by 94
Self-citationLee, M., Choi, H. J., Choi, J. Y., Song, M., Song, Y., Kim, S., Chang, H., Jung, S.-I., Ys, K., Ki, H. K., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.11.004 · Cited by 69
Salvador, E., Wagenlehner, F., Köhler, C.-D., Mellmann, A., Hacker, J. H., Svanborg, C., & Dobrindt, U. (2011) · Infection and Immunity · doi:10.1128/iai.06191-11 · Cited by 66
Owens, R. C., Johnson, J. R., Stogsdill, P., Yarmus, L. B., Lolans, K., & Quinn, J. P. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00993-11 · Cited by 49
Self-citationExtraintestinal isolates ofEscherichia coli: identification and prospects for vaccine development
Russo, T. A., & Johnson, J. R. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.1.45 · Cited by 34
Self-citation
Cited by
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Self-citationMathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Environmental Escherichia coli : ecology and public health implications-a review
Jang, J., Hur, H.-G., Sadowsky, M. J., Byappanahalli, M. N., Yan, T., & Ishii, S. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13468 · Cited by 849
Global dissemination of a multidrug resistant Escherichia coli clone
Petty, N. K., Ben Zakour, N. L., Stanton-Cook, M., Skippington, E., Totsika, M., Forde, B. M., Phan, M.-D., Gomes Moriel, D., Peters, K. M., Davies, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322678111 · Cited by 558
Price, L. B., Johnson, J. R., Aziz, M., Clabots, C., Johnston, B., Tchesnokova, V., Nordstrom, L., Billig, M., Chattopadhyay, S., Stegger, M., et al. (2013) · mBio · doi:10.1128/mbio.00377-13 · Cited by 464
Self-citation
Metadata
- Authors
- Johnson, J. R., Tchesnokova, V., Johnston, B., Clabots, C., Roberts, P. L., Billig, M., Riddell, K., Rogers, P., Qin, X., Butler-Wu, S., Price, L. B., Aziz, M., Nicolas-Chanoine, M.-H., DebRoy, C., Robicsek, A., Hansen, G., Urban, C., Platell, J., Trott, D. J., Zhanel, G., Weissman, S. J., Cookson, B. T., Fang, F. C., Limaye, A. P., Scholes, D., Chattopadhyay, S., Hooper, D. C., & Sokurenko, E. V.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-03
- Volume
- 207
- Issue
- 6
- Pages
- 919-928
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139852129
- Cited by
- 269
- References
- 25
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.